Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00074308
Status:
COMPLETED
Last Update Posted:
2018-06-20
First Post:
2003-12-10
Brief Title:
Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-10
Start Date Type:
None
Primary Completion Date:
2009-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-07
Completion Date Type:
ACTUAL
First Submit Date:
2003-12-10
First Submit QC Date:
December 10 2003
Study First Post Date:
2003-12-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-01-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-23
Last Update Post Date:
2018-06-20
Last Update Post Date Type:
ACTUAL